List of bibliographic references
Number of relevant bibliographic references: 20.
Ident. | Authors (with country if any) | Title |
---|
000425 (2014) |
M. Anheim [France] | [Triple-gene therapy in Parkinson disease (ProSavin): toward a putaminal dopamine factory?]. |
000439 (2014) |
David Devos [France] ; Caroline Moreau ; Jean Christophe Devedjian ; Jérome Kluza ; Maud Petrault ; Charlotte Laloux ; Aurélie Jonneaux ; Gilles Ryckewaert ; Guillaume Garçon ; Nathalie Rouaix ; Alain Duhamel ; Patrice Jissendi ; Kathy Dujardin ; Florent Auger ; Laura Ravasi ; Lucie Hopes ; Guillaume Grolez ; Wance Firdaus ; Bernard Sablonnière ; Isabelle Strubi-Vuillaume ; Noel Zahr ; Alain Destée [France] ; Jean-Christophe Corvol ; Dominik Pöltl ; Marcel Leist ; Christian Rose ; Luc Defebvre [France] ; Philippe Marchetti ; Z Ioav Cabantchik ; Régis Bordet | Targeting chelatable iron as a therapeutic modality in Parkinson's disease. |
000614 (2013) |
Béatrice Garcin [France] ; Emmanuel Roze ; Francine Mesrati ; Emmanuel Cognat ; Emmanuel Fournier ; Marie Vidailhet ; Bertrand Degos | Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. |
000682 (2013) |
Caroline Moreau [France] ; Arnaud Delval ; Vincent Tiffreau ; Luc Defebvre [France] ; Kathy Dujardin ; Alain Duhamel ; Gregory Petyt ; Claude Hossein-Foucher ; David Blum ; Bernard Sablonnière ; Susanna Schraen ; Delphine Allorge ; Alain Destée [France] ; Régis Bordet ; David Devos | Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study. |
000838 (2012) |
Olivier Rascol [France] ; Joaquim Ferreira ; Laurence Nègre-Pages ; Santiago Perez-Lloret ; Lucette Lacomblez ; Monique Galitzky ; Jean-Christophe Lemarié ; Jean-Christophe Corvol ; Jonathan M. Brotchie ; Laura Bossi | A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease. |
000B80 (2008) |
Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees ; Marina Aristin ; Laurence Salin ; Nolwenn Juhel ; Lisa Waldhauser ; Thomas Schindler | Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study. |
000C54 (2007) |
Aurélie Kas [France] ; Pierre Payoux ; Marie-Odile Habert ; Zoulikha Malek ; Yann Cointepas ; Georges El Fakhri ; Philippe Chaumet-Riffaud ; Emmanuel Itti ; Philippe Remy | Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images. |
000D12 (2007) |
G. Villafane [France] ; P. Cesaro ; A. Rialland ; S. Baloul ; S. Azimi ; C. Bourdet ; J. Le Houezec ; I. Macquin-Mavier ; P. Maison | Chronic high dose transdermal nicotine in Parkinson's disease: an open trial. |
000E02 (2006) |
Alice Villéger [France] ; Lemlih Ouchchane ; Jean-Jacques Lemaire ; Jean-Yves Boire | Assistance to planning in deep brain stimulation: data fusion method for locating anatomical targets in MRI. |
001016 (2003) |
Christine Brefel-Courbon [France] ; Karine Desboeuf ; Claire Thalamas ; Monique Galitzky ; Jean-Michel Senard ; Olivier Rascol ; Jean-Louis Montastruc | Clinical and economic analysis of spa therapy in Parkinson's disease. |
001136 (2001) |
O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. |
001346 (1998) |
J L Montastruc [France] ; M. Pelat ; P. Verwaerde ; C. Brefel-Courbon ; M A Tran ; O. Blin ; O. Rascol ; J M Senard | Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study. |
001394 (1997) |
F. Durif [France] ; M. Vidailhet ; F. Assal ; C. Roche ; A M Bonnet ; Yves Agid [France] | Low-dose clozapine improves dyskinesias in Parkinson's disease. |
001472 (1995) |
J L Montastruc [France] ; O. Rascol ; J M Senard ; G. Houin ; A. Rascol | Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? |
001474 (1995) |
A. Benazzouz [France] ; T. Boraud ; P. Dubédat ; A. Boireau ; J M Stutzmann ; C. Gross | Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. |
001553 (1994) |
J L Montastruc [France] ; O. Rascol ; J M Senard ; A. Rascol | A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. |
001699 (1989) |
E. Pourcher [France] ; A M Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France] | Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease. |
001790 (????) |
Pierre Koskas [France] ; Sandryne Stirati ; Jérôme Lagadec ; Jean-Guillaume Desban ; C. Legrand ; Florence Lebon ; Anne-Sophie Gaudin ; Claire Pent ; Olivier Drunat ; Yves Wolmark | [Multidisciplinary management of elderly patients with Parkinson's disease]. |
001815 (????) |
J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre | Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. |
001816 (????) |
P. Cesaro [France] ; M. Peschanski ; J P N'Guyen | Treatment of Parkinson's disease by cell transplantation. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Pilot Projects"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i \
-Sk "Pilot Projects" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Checkpoint
|type= indexItem
|index= Mesh.i
|clé= Pilot Projects
}}
| This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 | |